A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant Depression

Esketamine 56 mgOngoingRecruitingPhase 3Open NCT07716098 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…

NCT07716098 · Trial Tracker · ComplyRx